IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v34y2016i3p259-272.html
   My bibliography  Save this article

Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges

Author

Listed:
  • Jordana Schmier
  • Carolyn Hulme-Lowe

Abstract

Age-related macular degeneration (AMD) is a common ophthalmic condition that can have few symptoms in its early stage but can progress to major visual impairment. While there are no treatments for early-stage AMD, there are multiple modalities of treatment for advanced disease. Given the increasing prevalence of the disease, there are dozens of analyses of cost effectiveness of AMD treatments, but methods and approaches vary broadly. The goal of this review was to identify, characterize, and critique published models in AMD and provide guidance for their interpretation. After a literature review was performed to identify studies, and exclusion criteria applied to limit the review to studies comparing treatments for AMD, we compared methods across the 36 studies meeting the review criteria. To some extent, variation was related to targeting different audiences or acknowledging the most appropriate population for a given treatment. However, the review identified potential areas of uncertainty and difficulty in interpretation, particularly regarding duration of observation periods and the importance of visual acuity as an endpoint or a proxy for patient-reported utilities. We urge thoughtful consideration of these study characteristics when comparing results. Copyright Springer International Publishing Switzerland 2016

Suggested Citation

  • Jordana Schmier & Carolyn Hulme-Lowe, 2016. "Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges," PharmacoEconomics, Springer, vol. 34(3), pages 259-272, March.
    • Handle: RePEc:spr:pharme:v:34:y:2016:i:3:p:259-272
    DOI: 10.1007/s40273-015-0347-y
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s40273-015-0347-y
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/s40273-015-0347-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Thomas Butt & Praveen Patel & Adnan Tufail & Gary Rubin, 2014. "Modelling Cost Effectiveness in Neovascular Age-Related Macular Degeneration: The Impact of Using Contrast Sensitivity vs. Visual Acuity," Applied Health Economics and Health Policy, Springer, vol. 12(3), pages 289-297, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Thomas Butt & Adnan Tufail & Gary Rubin, 2017. "Health State Utility Values for Age-Related Macular Degeneration: Review and Advice," Applied Health Economics and Health Policy, Springer, vol. 15(1), pages 23-32, February.
    2. Jordana K. Schmier & Carolyn K. Hulme-Lowe, 2016. "Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges," PharmacoEconomics, Springer, vol. 34(3), pages 259-272, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:34:y:2016:i:3:p:259-272. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.